Tuesday, April 24, 2007 12:43:50 AM
A follow up from my last post...
http://www.balchem.com/core/newsletter_details.asp?ArticleID=319
New Hampton, New York, April 2, 2007 - Balchem Corporation (NASDAQ: BCPC) today announced that its European subsidiary, Balchem, B.V. entered into an agreement under which it will acquire the choline chloride and methylamines businesses located in Marano Ticino, Italy from Akzo Nobel Chemicals S.p.A. Akzo Nobel is a global leader in the chemical industry, and its Marano Ticino operation employs approximately eighty people, manufacturing and distributing choline, methylamines and derivative products to customers around the world.
"This acquisition provides a production platform that will enable us to better serve the expanding worldwide human and animal choline chloride demand and it also adds a direct commercial European presence, which we now deem necessary. In addition to choline nutritional products, we gain access to production and technology for methylamines, metam sodium and other products for various industrial applications. This platform should provide many opportunities for Balchem to leverage its global growth plans,” said Dino A. Rossi, President, CEO and Chairman of the Board of Directors of Balchem.
In 2006, this Akzo operation realized approximately US $35 million in revenue. This revenue, when added to Balchem's 2006 result and its other acquisition in 2007, raises Balchem revenues on a pro forma basis for 2006 to approximately $175 million from $101 million.
Choline chloride is an essential nutrient for optimum animal growth, and is integral in building, regulating, and maintaining cell membrane integrity and porosity. It also acts as a lipotropic agent, which aids in the utilization and outward transport of fat in the liver. Choline chloride and its derivatives are also used in many other industrial applications. Methylamines are used as raw materials for the production of choline chloride and also widely used in many chemical and industrial applications.
Your trading and investment choices should be the result of your own due diligence.
Recent BCPC News
- Balchem Corporation Releases 2023 Sustainability Report • GlobeNewswire Inc. • 04/22/2024 11:00:00 AM
- Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024 • GlobeNewswire Inc. • 04/19/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 11:18:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:30:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:32:14 PM
- Balchem Corporation to Participate at the BNP Paribas Exane 12th Consumer Ingredients Conference on March 14, 2024 • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:58:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 09:57:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:11:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:41:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:37:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 10:08:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 10:12:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 10:12:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 09:55:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/16/2024 10:26:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 12:14:27 PM
- Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/16/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 12:09:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:58:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:55:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:00:07 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:59:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:54:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:48:28 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM